ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,598.80
0.38%
S&P ASX All Technology
2,982.40
0.46%
Brent Oil
83.895
0.42%
US Dollar vs AUD
1.53015
-0.05%
Bitcoin
57,212.55
-1.76%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Corcept Therapeutics Inc (CORT)

  7. Corcept Therapeutics Inc (CORT) News

CORT Corcept Therapeutics Inc

26.90
3.58 (15.35%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Corcept Therapeutics Inc CORT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
3.58 15.35% 26.90 10:00:00
Open Price Low Price High Price Close Price Previous Close
23.09 22.60 24.61 23.88 23.32
more quote information »

Recent News

Date Time Source Heading
02/5/202406:05GLOBECorcept Therapeutics Announces First Quarter Financial..
29/4/202422:00GLOBECorcept Completes Enrollment in Phase 4 CATALYST Trial
25/4/202406:05GLOBECorcept Therapeutics to Announce First Quarter Financial..
22/4/202422:00GLOBECorcept Announces Positive Results From Open-Label Portion..
15/4/202422:00GLOBECorcept Completes Enrollment in Phase 2 DAZALS Trial in..
08/4/202422:00GLOBECorcept Completes Enrollment in Pivotal Phase 3 Rosella..
01/4/202423:00GLOBECorcept Completes Enrollment in Phase 3 Gradient Trial of..
06/3/202413:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202413:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202413:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202413:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202413:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202412:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202409:24EDGAR2Form 144 - Report of proposed sale of securities
22/2/202413:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202412:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202404:12EDGAR2Form 144 - Report of proposed sale of securities
16/2/202408:17EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
16/2/202408:11EDGAR2Form 8-K - Current report
16/2/202408:07GLOBECorcept Therapeutics Announces Fourth Quarter and Full-Year..
16/2/202408:02GLOBECorcept Announces Preliminary Results From Prevalence Phase..
16/2/202407:45EDGAR2Form 144 - Report of proposed sale of securities
15/2/202408:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202412:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202412:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202412:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202412:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202411:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202411:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202411:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202408:46EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
13/2/202411:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202408:05GLOBECorcept Therapeutics to Announce Fourth Quarter and..
03/2/202409:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202406:17EDGAR2Form 144 - Report of proposed sale of securities
30/1/202400:00GLOBECorcept Appoints Roberto Vieira as President, Oncology
23/1/202407:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/1/202412:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202400:06EDGAR2Form 8-K - Current report
09/1/202400:00GLOBECorcept Therapeutics Provides Financial Update and Announces..
05/1/202411:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202403:24EDGAR2Form 144 - Report of proposed sale of securities
03/1/202400:06EDGAR2Form 8-K - Current report
03/1/202400:00GLOBECourt Finds Corcept Therapeutics’ Patents Not Infringed
23/12/202311:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202304:09EDGAR2Form 144 - Report of proposed sale of securities
20/12/202310:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202313:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202312:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202308:34EDGAR2Form 8-K - Current report

Your Recent History

NASDAQ
CORT
Corcept Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved